Mereo BioPharma Group plc
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2023 | $-9.2M | $-9.2M | — | $1.6M |
| Jun 2023 | $-7.8M | $-7.8M | — | $941.0K |
| Sep 2023 | $2.7M | $2.7M | — | $1.5M |
| Dec 2023 | $-6.8M | $-6.8M | — | $815.0K |
| Mar 2024 | $-8.0M | $-8.0M | $0 | $2.1M |
| Jun 2024 | $-7.9M | $-7.9M | $0 | $2.1M |
| Sep 2024 | $-7.5M | $-7.5M | $0 | $1.7M |
| Dec 2024 | $-9.4M | $-9.4M | $0 | $1.5M |
| Mar 2025 | $-8.3M | $-8.3M | $20.0K | $2.3M |
| Jun 2025 | $-7.7M | $-7.7M | $0 | $2.1M |
| Sep 2025 | $-7.3M | $-7.3M | $0 | $1.7M |
| Dec 2025 | $-7.7M | $-7.7M | $0 | $1.5M |
| Mar 2026 | $-4.3M | $-4.3M | $0 | $1.6M |
| Jun 2026 | $-6.0M | $-6.0M | $0 | $1.3M |